{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:54:32Z","timestamp":1767650072006},"reference-count":22,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.vaccine.2016.08.058","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T23:24:13Z","timestamp":1473463453000},"page":"5125-5131","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria"],"prefix":"10.1016","volume":"34","author":[{"given":"Zubairu","family":"Iliyasu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harish","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kehinde T.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Nwaze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina","family":"Ahmad-Shehu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binta Wudil","family":"Jibir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garba Dayyabu","family":"Gwarzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auwalu U.","family":"Gajida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Weldon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Steven Oberste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Takane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Mkanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ado J.G.","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland W.","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.08.058_b0005","unstructured":"World Health Assembly. Global eradication of poliomyelitis by the year 2000. WHA41.28. [14 September 2015]. Available from: http:\/\/www.who.int\/ihr\/polioresolution4128en.pdf."},{"key":"10.1016\/j.vaccine.2016.08.058_b0010","doi-asserted-by":"crossref","first-page":"470","DOI":"10.15585\/mmwr.mm6518a4","article-title":"Progress toward polio eradication \u2014 worldwide, 2015\u20132016","volume":"65","author":"Morales","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.08.058_b0015","unstructured":"GPEI. Global eradication of wild poliovirus type 2 declared; 2015. Available from: http:\/\/www.polioeradication.org\/mediaroom\/newsstories\/Global-eradication-of-wild-poliovirus-type-2-declared\/tabid\/526\/news\/1289\/Default.aspx."},{"issue":"45","key":"10.1016\/j.vaccine.2016.08.058_b0020","first-page":"1031","article-title":"Possible eradication of wild poliovirus type 3 \u2013 worldwide, 2012","volume":"63","author":"Kew","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.08.058_b0025","unstructured":"WHO. World Health Organization removes Nigeria from polio endemic list. [15 September 2015]. Available from: http:\/\/www.who.int\/mediacentre\/news\/releases\/2015\/nigeria-polio\/en\/."},{"issue":"45","key":"10.1016\/j.vaccine.2016.08.058_b0030","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.15585\/mmwr.mm6445a4","article-title":"Progress toward poliomyelitis eradication \u2014 Pakistan, January 2014\u2013September 2015","volume":"64","author":"Noha","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"41","key":"10.1016\/j.vaccine.2016.08.058_b0035","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.15585\/mmwr.mm6441a2","article-title":"Progress toward poliomyelitis eradication \u2014 Afghanistan, January 2014\u2013August 2015","volume":"64","author":"Mbaeyi","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.08.058_b0040","unstructured":"GPEI. Data and monitoring. Wild poliovirus. [10 August 2016]. Available from: http:\/\/www.polioeradication.org\/Dataandmonitoring\/Poliothisweek.aspx."},{"key":"10.1016\/j.vaccine.2016.08.058_b0045","unstructured":"GPEI. Key countries. Nigeria. [10 August 2016]. Available from: http:\/\/www.polioeradication.org\/Keycountries\/Nigeria(cVDPV).aspx."},{"issue":"7","key":"10.1016\/j.vaccine.2016.08.058_b0050","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/infdis\/jiq140","article-title":"Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population","volume":"203","author":"Wassilak","year":"2011","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2016.08.058_b0055","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1128\/JVI.02954-12","article-title":"Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria","volume":"87","author":"Burns","year":"2013","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2016.08.058_b0060","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.vaccine.2013.08.060","article-title":"Survey of poliovirus antibodies in Kano, Northern Nigeria","volume":"32","author":"Iliyasu","year":"2014","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2016.08.058_b0065","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1093\/infdis\/jiv774","article-title":"Role of serial polio seroprevalence studies in guiding implementation of the polio eradication initiative in Kano, Nigeria: 2011\u20132014","volume":"213","author":"Craig","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.058_b0070","doi-asserted-by":"crossref","first-page":"f954","DOI":"10.1136\/bmj.f954","article-title":"Murder of nine polio workers in Nigeria threatens eradication efforts","volume":"346","author":"Arie","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2016.08.058_b0075","unstructured":"WHO. Report of a WHO informal consultation on polio neutralizing antibody assays. WHO\/EPI\/RD\/91.3 Rev 1; 1991."},{"issue":"5","key":"10.1016\/j.vaccine.2016.08.058_b0080","first-page":"1097","article-title":"World Health Organization collaborative study group on oral poliovirus vaccine","volume":"171","author":"Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.058_b0085","unstructured":"WHO Anthro version 3.2.2; 2011. [14 September 2015]. Available from: http:\/\/www.who.int\/childgrowth\/software\/en\/."},{"key":"10.1016\/j.vaccine.2016.08.058_b0090","unstructured":"WHO. The WHO child growth standards. [08 June 2016]. Available from: http:\/\/www.who.int\/childgrowth\/standards\/en\/."},{"key":"10.1016\/j.vaccine.2016.08.058_b0095","unstructured":"US Census Bureau. Census and survey processing system (CSPro). [14 September 2014]. Available from: http:\/\/www.census.gov\/population\/international\/software\/cspro\/."},{"key":"10.1016\/j.vaccine.2016.08.058_b0100","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2015. Available from: https:\/\/www.r-project.org\/."},{"issue":"27","key":"10.1016\/j.vaccine.2016.08.058_b0105","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1016\/j.vaccine.2007.04.022","article-title":"Survey of poliovirus antibodies during the final stage of polio eradication in Egypt","volume":"25","author":"El-Sayed","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.058_b0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1473-3099(11)70190-6","article-title":"Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6\u20139 months in Moradabad, India: a community-based, randomised controlled trial","volume":"12","author":"Estivariz","year":"2012","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T15:30:18Z","timestamp":1536420618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16307459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":22,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0264410X16307459"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}